Mereo BioPharma (MREO) - Bathi resik saben saham (EPS TTM)

Mereo BioPharma is scaling the development of orphan drugs through strategic alliances, while the TTM earnings per share chart on GURU.Markets shows that this metric equals -0.17. Business growth relies on the automation of substance synthesis with physician-monitored testing, and medium-term potential is driven by the expected results of the final phase trials for its drug treating osteogenesis imperfecta.

MREO (mereobiopharma.com) riwayat Bathi saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 13.11.2026

Rincian metrik komprehensif lan analitis Mereo BioPharma Group (MREO)

- rega saham lan prakiraan rega para ahli:

Kutipan saham Mereo BioPharma Group PLC|MREO - Bagan tingkat prakiraan

- indikator kapitalisasi pasar:

Kapitalisasi pasar Mereo BioPharma Group plc|MREO - Total Nilai Perusahaan

- rincian valuasi buku bisnis:

Nilai Buku saben Saham Mereo BioPharma|MREO - Kapitalisasi Akuntansi|Rasio Kapitalisasi marang Aset Bersih mereobiopharma.com|MREO - Nilai Agregat Aset

- rincian utang lan likuiditas:

Utang marang Ekuitas Mereo BioPharma|MREO - Kewajiban jangka dawa marang ekuitas|Utang jangka cendhak marang modal Mereo BioPharma Group PLC|MREO - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Mereo BioPharma Group plc|MREO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Mereo BioPharma|Likuiditas cepet mereobiopharma.com

- indikator pendapatan resik lan kelipatan nilai:

MREO - Penghasilan resik|Proyeksi bathi mangsa ngarep Mereo BioPharma|MREO - Pangali P/E|Rega marang bathi mangsa ngarep Mereo BioPharma Group PLC|MREO - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Mereo BioPharma Group plc|MREO - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Mereo BioPharma|MREO - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan mereobiopharma.com|MREO - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Mereo BioPharma

- informasi babagan volume dodolan lan pendapatan:

MREO - Total pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Mereo BioPharma Group PLC|MREO - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S Mereo BioPharma Group plc

Analisis umum perusahaan:mereobiopharma.com (MREO)

The development of orphan drugs by Mereo BioPharma (MREO) possesses exceptional macro-resilience, as demand for specialized therapies remains independent of economic cycles and seasonality. The earnings per share trend over the last four quarters reflects the ultimate efficiency of capital management, allowing investors to assess the real profitability of the business per share and forecast the stability of the asset's market capitalization.

Pesaing Mereo BioPharma (MREO)